PRAZOSIN HCL
ALPHA-BLOCKERS · HYPERTENSION
DIRECT RX
Drug class
Alpha-Blockers
Alpha-blockers, formally designated as alpha-adrenergic receptor antagonists, are a class of pharmacologic agents that selectively or nonselectively inhibit the action of norepinephrine and epinephrine at alpha-adrenergic receptors. Read more about Alpha-Blockers
184 drugs in this class 89 manufacturers
Drugs in Alpha-Blockers
TAMSULOSIN HCL
ALPHA-BLOCKERS · BENIGN PROSTATIC HYPERPLASIA WITH LOWER URINARY TRACT SYMPTOM
DIRECT RX
DOXAZOSIN MESYLATE
ALPHA-BLOCKERS · HYPERTENSION ·+1
CHARTWELL RX LL
LABETALOL HCL
ALPHA-BLOCKERS · HYPERTENSION
CHARTWELL RX LL
TAMSULOSIN HCL
ALPHA-BLOCKERS · BENIGN PROSTATIC HYPERPLASIA WITH LOWER URINARY TRACT SYMPTOM
CHARTWELL RX LL
TERAZOSIN HCL
ALPHA-BLOCKERS · HYPERTENSION ·+1
CHARTWELL RX LL
PRAZOSIN HCL
ALPHA-BLOCKERS · HYPERTENSION
ALEMBIC PHARMAC
PRAZOSIN HCL
ALPHA-BLOCKERS · HYPERTENSION
ANI PHARMACEUTI
PRAZOSIN HCL
ALPHA-BLOCKERS · HYPERTENSION
AHP
Filter & compare in the drug finder →
Opens the drug finder with Alpha-Blockers preselected. Add indication or manufacturer filters there.
Alpha-blockers, formally designated as alpha-adrenergic receptor antagonists, are a class of pharmacologic agents that selectively or nonselectively inhibit the action of norepinephrine and epinephrine at alpha-adrenergic receptors.
By blocking these receptors on vascular and nonvascular smooth muscle, they promote vasodilation and decrease smooth muscle tone.
Clinically, these medications are primarily utilized to improve urinary flow in benign prostatic hyperplasia, reduce peripheral vascular resistance in essential hypertension, and control blood pressure spikes associated with pheochromocytoma.
-
nih.gov
Alpha-blockers, formally designated as alpha-adrenergic receptor antagonists, are a class of pharmacologic agents that selectively or nonselectively inhibit the action of norepinephrine and epinephrine at alpha-adrenergic receptors Clinically, these medications are primarily utilized to improve urinary flow in benign prostatic hyperplasia, reduce peripheral vascular resistance in essential hypertension, and control blood pressure spikes associated with pheochromocytoma
-
nih.gov
By blocking these receptors on vascular and nonvascular smooth muscle, they promote vasodilation and decrease smooth muscle tone
-
nih.gov
By blocking these receptors on vascular and nonvascular smooth muscle, they promote vasodilation and decrease smooth muscle tone
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.